RecruitingNot ApplicableNCT07483723

Glucose Profiles in Women With Polycystic Ovary Syndrome


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

80 participants

Start Date

Jan 6, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking blood sugar levels continuously in women with polycystic ovary syndrome (PCOS) — a hormonal condition that can cause irregular periods, excess male hormones, and cysts on the ovaries. PCOS increases the risk of developing diabetes, and researchers want to understand how blood sugar fluctuates in these women to better prevent or detect diabetes early. **You may be eligible if...** - You are over 18 years old and have been diagnosed with PCOS (based on irregular periods, signs of elevated male hormones, or ovarian cysts on ultrasound) - You are willing to wear a continuous glucose monitor (the FreeStyle Libre sensor) - You can provide written informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have another condition that could mimic PCOS (such as high prolactin, thyroid disorder, Cushing's syndrome, or a hormone-producing tumor) - You already have diabetes - You have used certain medications in the past 3 months, including hormonal contraceptives, anti-androgen drugs, diabetes medications, or inositol supplements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEsensor

Free-style-libre pro sensor application for 14 days

DEVICEAge reader

Analysis of glycation end products by AGE reader


Locations(1)

CHRU Amiens

Salouël, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07483723


Related Trials